ACADIA PHARMACEUTICALS INC financial data

Symbol
ACAD on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 314% % 41%
Quick Ratio 34% % 45%
Debt-to-equity 41% % -43%
Return On Equity 42% % 6%
Return On Assets 30% % 29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 170,494,613 shares 1.9%
Common Stock, Shares, Outstanding 170,309,376 shares 2.2%
Entity Public Float $2,300,000,000 USD 15%
Common Stock, Value, Issued $16,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 168,356,000 shares 1.6%
Weighted Average Number of Shares Outstanding, Diluted 169,919,000 shares 2.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,071,505,000 USD 12%
Research and Development Expense $328,802,000 USD 8.4%
Costs and Expenses $966,694,000 USD 33%
Operating Income (Loss) $104,811,000 USD -55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $138,904,000 USD -46%
Income Tax Expense (Benefit) $252,096,000 USD -897%
Net Income (Loss) Attributable to Parent $391,000,000 USD 73%
Earnings Per Share, Basic 2.32 USD/shares 69%
Earnings Per Share, Diluted 2.3 USD/shares 69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $177,695,000 USD -44%
Accounts Receivable, after Allowance for Credit Loss, Current $121,457,000 USD 23%
Inventory, Net $111,374,000 USD 21%
Assets, Current $1,062,113,000 USD 13%
Deferred Income Tax Assets, Net $249,879,000 USD
Property, Plant and Equipment, Net $7,511,000 USD 78%
Operating Lease, Right-of-Use Asset $47,354,000 USD 1.7%
Other Assets, Noncurrent $3,896,000 USD 985%
Assets $1,564,195,000 USD 32%
Accounts Payable, Current $10,903,000 USD -33%
Employee-related Liabilities, Current $45,579,000 USD 25%
Accrued Liabilities, Current $266,211,000 USD -30%
Liabilities, Current $277,114,000 USD -30%
Deferred Income Tax Liabilities, Net $11,162,000 USD -2.3%
Operating Lease, Liability, Noncurrent $40,554,000 USD -3.5%
Other Liabilities, Noncurrent $19,137,000 USD 6%
Liabilities $336,805,000 USD -26%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,445,000 USD 395%
Retained Earnings (Accumulated Deficit) $1,813,386,000 USD 18%
Stockholders' Equity Attributable to Parent $1,227,390,000 USD 67%
Liabilities and Equity $1,564,195,000 USD 32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $20,323,000 USD -30%
Net Cash Provided by (Used in) Financing Activities $1,838,000 USD 76%
Net Cash Provided by (Used in) Investing Activities $124,049,000 USD -784%
Common Stock, Shares Authorized 225,000,000 shares 0%
Common Stock, Shares, Issued 170,309,376 shares 2.2%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $101,893,000 USD -733%
Deferred Tax Assets, Valuation Allowance $114,603,000 USD -75%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.211 pure
Deferred Tax Assets, Gross $375,644,000 USD -19%
Operating Lease, Liability $52,187,000 USD 0.37%
Depreciation $229,000 USD -5.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $392,153,000 USD 73%
Lessee, Operating Lease, Liability, to be Paid $58,540,000 USD -1.5%
Property, Plant and Equipment, Gross $16,995,000 USD 18%
Operating Lease, Liability, Current $11,633,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,938,000 USD 30%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,966,000 USD 17%
Operating Lease, Weighted Average Discount Rate, Percent 0.048 pure 6.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,353,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $11,466,000 USD 24%
Deferred Tax Assets, Operating Loss Carryforwards $77,118,000 USD -34%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $41,578,000 USD 8.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four $10,612,000 USD 13%
Operating Lease, Payments $12,114,000 USD 17%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,722,000 USD -49%
Deferred Tax Assets, Net of Valuation Allowance $39,400,000 USD 353%
Share-based Payment Arrangement, Expense $52,135,000 USD -22%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%